PRESTIGE CONSUMER HEALTHCARE INC. Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent of $0 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent · last filed 2023-11-02
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2023-09-30 was $0.00.
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2022-12-31 was $0.00.
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2022-09-30 was $0.00.
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2022 was -$246.00K.
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2021 was -$1.17M, a 198.74% decline from fiscal 2020.
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2020 was $1.19M.
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2019 was -$48.00K.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | ||||
| 2022-12-31 | $0.00 10-Q · filed 2023-02-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $790.00K 10-Q · filed 2023-02-02 | $544.00K derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-02 | $790.00K 10-Q · filed 2023-11-02 | $544.00K derived: sum of 3 quarters · filed 2023-11-02 | $544.00K derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $790.00K 10-Q · filed 2023-08-03 | $544.00K derived: sum of 2 quarters · filed 2023-08-03 | $544.00K derived: sum of 3 quarters · filed 2023-08-03 | $544.00K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-06 | -$246.00K derived: sum of 2 quarters · filed 2023-02-02 | -$246.00K derived: sum of 3 quarters · filed 2023-02-02 | -$246.00K 10-K · filed 2022-05-06 | |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-02 | $0.00 derived: sum of 2 quarters · filed 2023-02-02 | $0.00 10-Q · filed 2023-02-02 | $1.16M derived: sum of 4 quarters · filed 2023-02-02 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $1.16M derived: sum of 3 quarters · filed 2022-11-03 | -$1.17M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $1.16M derived: sum of 2 quarters · filed 2022-08-04 | -$1.17M derived: sum of 3 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-06 | -$1.17M derived: sum of 2 quarters · filed 2022-05-06 | -$1.17M 10-K · filed 2022-05-06 | ||
| 2020-12-31 | -$2.33M 10-Q · filed 2022-02-03 | -$2.33M 10-Q · filed 2022-02-03 | |||
| 2020-03-31 | $1.19M 10-K · filed 2020-05-08 | $1.19M derived: sum of 2 quarters · filed 2021-02-04 | $1.19M derived: sum of 3 quarters · filed 2021-02-04 | $1.19M 10-K · filed 2022-05-06 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-04 | $0.00 derived: sum of 2 quarters · filed 2021-02-04 | $0.00 10-Q · filed 2021-02-04 | -$48.00K derived: sum of 4 quarters · filed 2021-02-04 | |
| 2019-09-30 | $0.00 10-K · filed 2020-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-05-08 | -$48.00K derived: sum of 3 quarters · filed 2020-05-08 | -$48.00K derived: sum of 4 quarters · filed 2020-05-08 | |
| 2019-06-30 | $0.00 10-K · filed 2020-05-08 | -$48.00K derived: sum of 2 quarters · filed 2020-05-08 | -$48.00K derived: sum of 3 quarters · filed 2020-05-08 | -$48.00K derived: sum of 4 quarters · filed 2020-05-08 | |
| 2019-03-31 | -$48.00K 10-K · filed 2020-05-08 | -$48.00K derived: sum of 2 quarters · filed 2020-05-08 | -$48.00K derived: sum of 3 quarters · filed 2020-05-08 | -$48.00K 10-K · filed 2021-05-07 | |
| 2018-12-31 | $0.00 10-K · filed 2020-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-05-08 | $0.00 10-Q · filed 2019-02-07 | -$1.33M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-09-30 | $0.00 10-K · filed 2020-05-08 | $0.00 10-Q · filed 2018-11-01 | -$1.33M derived: sum of 3 quarters · filed 2020-05-08 | -$1.33M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-06-30 | $0.00 10-K · filed 2020-05-08 | -$1.33M derived: sum of 2 quarters · filed 2020-05-08 | -$1.33M derived: sum of 3 quarters · filed 2020-05-08 | -$1.33M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-03-31 | -$1.33M 10-K · filed 2019-05-13 | $1.33M 10-K · filed 2018-05-10 | -$1.33M derived: sum of 2 quarters · filed 2019-05-13 | -$1.33M derived: sum of 3 quarters · filed 2019-05-13 | -$1.33M 10-K · filed 2020-05-08 |
| 2017-12-31 | $0.00 10-K · filed 2019-05-13 | $0.00 derived: sum of 2 quarters · filed 2019-05-13 | -$1.00K 10-Q · filed 2019-02-07 | -$253.00K derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-09-30 | $0.00 10-K · filed 2019-05-13 | -$1.00K 10-Q · filed 2018-11-01 | -$253.00K derived: sum of 3 quarters · filed 2019-05-13 | -$253.00K derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-06-30 | -$1.00K 10-K · filed 2019-05-13 | -$253.00K derived: sum of 2 quarters · filed 2019-05-13 | -$253.00K derived: sum of 3 quarters · filed 2019-05-13 | -$253.00K derived: sum of 4 quarters · filed 2019-05-13 | |
| 2017-03-31 | -$252.00K 10-K · filed 2018-05-10 | $252.00K 10-K · filed 2017-05-17 | -$252.00K derived: sum of 2 quarters · filed 2018-05-10 | -$252.00K derived: sum of 3 quarters · filed 2018-05-10 | $252.00K 10-K · filed 2019-05-13 |
| 2016-12-31 | $0.00 10-K · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-05-10 | $0.00 10-Q · filed 2018-02-01 | ||
| 2016-09-30 | $0.00 10-K · filed 2018-05-10 | $0.00 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | $0.00 10-K · filed 2018-05-10 | ||||
| 2016-03-31 | $0.00 10-K · filed 2018-05-10 | ||||
| 2015-03-31 | $0.00 10-K · filed 2017-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |